Early safety study of an investigational drug in healthy adults
Part of Infections clinical trials.
This study tests an investigational drug called AZD0543 to see if it is safe and how the body processes it. It is for healthy adults, not for treating a specific disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 55 years old
- Weigh between 45 and 110 kg with a body mass index (BMI) between 18 and 30
- Be in good health with no significant medical conditions
- Not have active infections like hepatitis B or C
- Not have a history of cancer (except certain skin cancers) in the last 5 years
- Not be pregnant or breastfeeding, and if you can have children, use highly effective birth control
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new vaccine that targets two respiratory viruses, RSV and HMPV, to see if it's safe and effective in adults 60 years and older. It may help prevent serious lung infections caused by these viruses.
This trial tests a new medicine to see how the body handles it and whether it is safe. It is for healthy people, not for treating a disease, and helps researchers decide if the drug can move to the next stage of testing.
This is an early-stage safety study testing a new investigational drug (VH4770359) in healthy volunteers. Researchers want to understand how the body processes the drug and ensure it is safe and well-tolerated.
This trial is testing a new intravenous medicine (ME3241) for safety and how the body handles it. It's for healthy adults, so researchers can see how the drug works before testing it in people with the target condition.
This study tests an experimental medication in healthy volunteers to see how it is processed by the body and whether it is safe. You may not receive direct benefit, but your participation helps find better treatments for people with HIV.
This study tests a new vaccine that protects against two common respiratory viruses: RSV and HMPV. It aims to see if the vaccine is safe and works well in older adults, who are at higher risk for serious illness from these viruses.
Hear when a new Human Metapneumovirus Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.